Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Joint distribution approaches to simultaneously quantifying benefit and risk.

Michele L Shaffer1, Kristi L Watterberg

  • 1Department of Health Evaluation Sciences, Penn State College of Medicine, Hershey, PA, USA. mshaffer@hes.hmc.psu.edu

BMC Medical Research Methodology
|October 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parent-reported quality of life at school age among children born extremely preterm is associated with non-medical determinants of health and developmental outcomes.

Early human development·2026
Same author

Expectant Management vs Medication for Patent Ductus Arteriosus in Preterm Infants: The PDA Randomized Clinical Trial.

JAMA·2025
Same author

Hydrocortisone in Preterm Infants and School-Age Functional Outcomes: Follow-Up of a Randomized Clinical Trial.

JAMA pediatrics·2025
Same author

Early Intratracheal Budesonide to Reduce Bronchopulmonary Dysplasia in Extremely Preterm Infants: The Budesonide in Babies (BiB) Randomized Clinical Trial.

JAMA·2025
Same author

Social distancing and extremely preterm births in the initial COVID-19 pandemic period.

Journal of perinatology : official journal of the California Perinatal Association·2024
Same author

Hydrocortisone in very preterm neonates for BPD prevention: meta-analysis and effect size modifiers.

Archives of disease in childhood. Fetal and neonatal edition·2024

The benefit-risk ratio can be difficult to interpret with small sample sizes. Visualizing the joint distribution of benefit and risk offers a clearer understanding of treatment tradeoffs, especially with Bayesian methods.

Area of Science:

  • Biostatistics
  • Clinical Trial Analysis
  • Health Economics

Background:

  • The benefit-risk ratio is a metric used to assess the balance between therapeutic benefits and adverse events.
  • Traditional benefit-risk ratio calculations can yield unstable confidence intervals with limited data or small effect sizes.
  • Existing methods may not adequately represent the complexities of simultaneous benefit and risk assessment.

Purpose of the Study:

  • To explore alternative methods for visualizing and quantifying the benefit-risk tradeoff in clinical trials.
  • To demonstrate the utility of the benefit-risk plane and Bayesian approaches for handling uncertainty.
  • To improve the interpretation of treatment efficacy and safety data.

Main Methods:

  • Constructing confidence regions in the benefit-risk plane using the joint distribution of benefit and risk.

Related Experiment Videos

  • Defining and analyzing regions of interest within the benefit-risk plane (e.g., acceptable risk).
  • Applying Bayesian methodology for a flexible and comprehensive analysis of benefit and risk.

    • Main Results:

    • Analysis of hydrocortisone trial data showed a wide confidence interval for the benefit-risk ratio in a specific infant subgroup.
    • Visualizing data in the benefit-risk plane confirmed uncertainty and allowed separate assessment of risk and benefit variability.
    • Bayesian analysis indicated a 72% probability of positive incremental net health benefit with hydrocortisone under specific risk tolerance.

    Conclusions:

    • Presenting the joint distribution of benefit and risk alongside the benefit-risk ratio is recommended to avoid ambiguity.
    • The benefit-risk plane offers a more nuanced visualization than single-dimension ratios.
    • Bayesian methods provide enhanced flexibility for simultaneously quantifying multiple aspects of benefit and risk.